Proceedings
| # | Title of the Talks | Page No | Download |
|---|---|---|---|
| 1 | Disrupted MuscleBrain Crosstalk through ApelinAPJ Signaling in Post-ICU Syndrome Yumiko Imai |
1 |  |
| 2 | PyruvateGPR31 axis induces LysoDC dendrite protrusion to M-cell pockets for effective immune responses in Peyers patches Eiji Umemoto |
2 | |
| 3 | Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination Zhe Li |
3 | |
| 4 | BACH2 drives the development and function of group 2 innate lymphoid cells Jun Wang |
4 | |
| 5 | Global Mapping of evidence on vaccination relatededucation delivery throughschool based curriculum A scoping review Bhupender Singh Khanuja |
5 | |
| 6 | Restructuring of the COVID-19 Vaccine Safety Committee 2020-2023 in Mexico Ana Maria Santibanez |
6 | |
| 7 | Endogenous L-glutathione rapidly degrades the vaccine additive thimerosal at pH 74 Juergen Gailer |
7 | |
| 8 | Prevalence of protective levels of anti-HBsantibodies among 15-17year old adolescents at Kawempe division Kampala-Uganda Nambafu Joan |
8 | |
| 9 | Influenza A-Associated Acute Necrotizing Encephalopathy Hawraman Ramadan |
9 | |
| 10 | Alisol B 23-acetate broadly inhibits coronavirus through blocking virus entry and suppresses proinflammatory T cells responses for COVID-19 treatment Jiangang Shen |
10 | |
| 11 | Socio-demographic correlates of COVID-19 Vaccine hesitancy among Men in Nigeria findings from the National population-based survey Olatunde Aremu |
11 | |
| 12 | The controversy around anti-amyloid antibodies for treating Alzheimers disease The European Medical Agencys ruling against the latest anti-amyloid drugs highlights the ongoing debate about their safety and efficacy Philip Anthony Hunter |
12 | |
| 13 | Evidence-Based Approach In Evaluation Of Laparoscopic Suture Repair For Perforated Peptic Ulcer Stanislav Panin |
13 | |
| 14 | Impact of COVID-19 Epidemic in the European Air Transport Command a Retrospective Descriptive Study Martin Gascon Hove |
14 | |
